RARE
Ultragenyx Pharmaceutical Inc
Price:  
40.98 
USD
Volume:  
1,097,115.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RARE Stock Forecast & Price Target

RARE Stock Price Forecast

The average stock forecast for Ultragenyx Pharmaceutical Inc (RARE) in the next 12 months is 94.81 USD. This price target corresponds to an upside of 131.36%. The range of stock forecasts for RARE is 48.48 - 147.00 USD. Based on the ratings of 27 analysts, the consensus recommendation for RARE is BUY.
Target Low Average Median High
Price (USD) 48.48 94.81 86.70 147.00
Upside 18.30% 131.36% 111.57% 258.71%

Recommendation Trends

The latest consensus rating for RARE is "BUY". This is the average recommendation of 27 analysts: 0 strong sell, 0 sell, 2 hold, 16 buy, 9 strong buy. In the previous period, 27 analysts also majorly recommmended "BUY" for RARE.

RARE Financial Stock Forecast

Revenue This Year
550.19M
26.70%
from 434.25M
Revenue Next Year
654.85M
19.02%
from 550.19M
EPS This Year
-6.30
-4.09%
from -6.57
EPS Next Year
-5.16
-18.18%
from -6.30